Company newsMRNA
Explain this story: Forge Nano and Nanexa Enter Joint Development Agreement to Advance Manufacturing for ALD-Coated PharmaShell® Long-Acting Injectable Medicines
Forge Nano and Nanexa have entered a Joint Development Agreement to advance manufacturing for ALD-coated PharmaShell® long-acting injectable medicines. This collaboration aims to develop large-scale, GMP-compliant ALD manufacturing equipment to support Nanexa’s PharmaShell® drug delivery platform and its portfolio of proprietary and partnered programs. The agreement will combine Nanexa’s drug delivery expertise with Forge Nano’s industrial ALD process development to create flexible and scalable manufacturing capabilities for a broad range of pharmaceutical products.
Othermarkets.businessinsider.comSector and industry: HealthcareBiotechnologyTell me moreShow less
We have not explained this story yet. The original headline, summary and link are below.
Forge Nano and Nanexa have entered a Joint Development Agreement to advance manufacturing for ALD-coated PharmaShell® long-acting injectable medicines. This collaboration aims to develop large-scale, GMP-compliant ALD manufacturing equipment to support Nanexa’s PharmaShell® drug delivery platform and its portfolio of proprietary and partnered programs. The agreement will combine Nanexa’s drug delivery expertise with Forge Nano’s industrial ALD process development to create flexible and scalable manufacturing capabilities for a broad range of pharmaceutical products.
Article tone: Positive This describes the words the journalist used. It is not a prediction, and not advice.